Intravenous magnesium sulphate in the treatment of vasospasm after aneurysmal SAH

T. Westermaier, C. Stetter, J. Eriskat, E. Kunze & K. Roosen
Objective: Secondary ischemic deficits due to cerebral vasospasm are still the major cause of in-hospital mortality and morbidity after aneurysmal SAH. Calcium antagonists have long been subject of clinical and experimental studies regarding neuroprotection in cerebral vascular insults. Magnesium has[for full text, please go to the a.m. URL]